J. K. Hess-Wilson

发表

Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment.

Russell S. Thomas, M. Andersen, H. Clewell, 2011, Toxicological sciences : an official journal of the Society of Toxicology.

Influence of the Nuclear Hormone Receptor Axis in the Progression and Treatment of Hormone Dependent Cancers

J. K. Hess-Wilson, 2007 .

Differences between Human and Rat Intestinal and Hepatic Bisphenol A Glucuronidation and the Influence of Alamethicin on In Vitro Kinetic Measurements

J. Lipscomb, J. K. Hess-Wilson, J. F. Kenneke, 2010, Drug Metabolism and Disposition.

Bisphenol A may reduce the efficacy of androgen deprivation therapy in prostate cancer

J. K. Hess-Wilson, 2009, Cancer Causes & Control.

2,2-Bis(4-Chlorophenyl)-1,1-Dichloroethylene Stimulates Androgen Independence in Prostate Cancer Cells through Combinatorial Activation of Mutant Androgen Receptor and Mitogen-Activated Protein Kinase Pathways

K. Knudsen, Y. Daaka, J. K. Hess-Wilson, 2008, Molecular Cancer Research.

Mitogenic action of the androgen receptor sensitizes prostate cancer cells to taxane-based cytotoxic insult.

K. Knudsen, J. K. Hess-Wilson, W. Zagorski, 2006, Cancer research.

Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer

G. Babcock, P. Limbach, K. Knudsen, 2006, Molecular Cancer Therapeutics.

Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells.

K. Knudsen, E. Knudsen, C. Comstock, 2007, Cancer research.

Xenoestrogen action in breast cancer: impact on ER-dependent transcription and mitogenesis

K. Knudsen, K. Weaver, J. K. Hess-Wilson, 2006, Breast Cancer Research and Treatment.

Unique Bisphenol A Transcriptome in Prostate Cancer: Novel Effects on ERβ Expression That Correspond to Androgen Receptor Mutation Status

K. Knudsen, C. Comstock, S. Ho, 2007, Environmental health perspectives.

Application of computational toxicological approaches in human health risk assessment. I. A tiered surrogate approach.

Dan D. Petersen, Jason C Lambert, N. C. Wang, 2012, Regulatory toxicology and pharmacology : RTP.

Endocrine disrupting compounds and prostate cancer.

K. Knudsen, J. K. Hess-Wilson, 2006, Cancer letters.

Cells Determinant of Therapeutic Response in Prostate Cancer Retinoblastoma Tumor Suppressor Status Is a Critical

K. Knudsen, E. Knudsen, C. Comstock, 2007 .